<DOC>
	<DOCNO>NCT03089827</DOCNO>
	<brief_summary>Participants enrol Alzheimer 's Disease Clinical Core Wake Forest School Medicine invite take part study . The purpose study identify measure amount protein call amyloid brain.It think build amyloid may relate development Alzheimer 's disease .</brief_summary>
	<brief_title>Biodistribution 11CPIB Patients With Risk Factors Alzheimer 's Disease</brief_title>
	<detailed_description>Brain amyloid measure use PET [ 11C ] PiB . Participation involve initial brain scan possibly follow-up brain scan two year later . The data collect study help explain amyloid deposit several group participant include adult without sign memory impairment . The information collect help find likely brain amyloid increase risk develop memory problem . Research study suggest people elevated level brain amyloid increase risk memory decline , mean every person amyloid build develop AD .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<criteria>Enrolled Alzheimer 's Disease Clinical Core</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Memory</keyword>
</DOC>